DOXYCIN TAB 100MG TABLET

Kraj: Kanada

Język: angielski

Źródło: Health Canada

Kup teraz

Składnik aktywny:

DOXYCYCLINE (DOXYCYCLINE HYCLATE)

Dostępny od:

LABORATOIRE RIVA INC.

Kod ATC:

J01AA02

INN (International Nazwa):

DOXYCYCLINE

Dawkowanie:

100MG

Forma farmaceutyczna:

TABLET

Skład:

DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100MG

Droga podania:

ORAL

Sztuk w opakowaniu:

10/20/100/300

Typ recepty:

Prescription

Dziedzina terapeutyczna:

TETRACYCLINES

Podsumowanie produktu:

Active ingredient group (AIG) number: 0105569001; AHFS:

Status autoryzacji:

MARKETED

Data autoryzacji:

1989-12-31

Charakterystyka produktu

                                _Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 1 of 25_
_ _
_ _
_ _
_ _
_ _
_ _
_ _
PRESCRIBING INFORMATION AND PATIENT MEDICATION INFORMATION
PR
DOXYCIN CAPSULES
100MG
Doxycycline Hyclate Capsules, USP
_100 mg doxycycline (as hyclate)_
PR
DOXYCIN TABLETS
100MG
Doxycycline Hyclate Tablets, USP
_100 mg doxycycline (as hyclate)_
Antibiotic
LABORATOIRE RIVA INC.
660 Industriel Blvd.
Blainville, Canada
J7C 3V4
www.labriva.com
Date of Revision:
April 5, 2018
Control #: 211564
_Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 2 of 25_
_ _
NAME OF DRUGS
PR
DOXYCIN CAPSULES
Doxycycline Hyclate Capsules, USP
_100mg doxycycline (as hyclate) _
PR
DOXYCIN TABLETS
Doxycycline Hyclate Tablets, USP
_100mg doxycycline (as hyclate)_
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
Doxycycline hyclate is a broad-spectrum antibiotic and is active
against a wide range of Gram-
negative and Gram-positive organisms. Doxycycline exerts its
bacteriostatic effect by the inhibition of
protein synthesis.
INDICATIONS AND CLINICAL USE
DOXYCIN CAPSULES AND DOXYCIN TABLETS
(doxycycline hyclate) may be indicated for
the treatment of:
Pneumonia:
Single and multilobe pneumonia and bronchopneumonia due to susceptible
strains of
_Streptococcus _
_pneunomiae_
and other
_Streptococcus_
spp.,
_Staphylococcus_
spp.,
_H. influenzae_
and
_Klebsiella _
_pneumoniae_
.
Other Respiratory Tract Infections:
Pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis caused
by susceptible strains of β-hemolytic
_Streptococcus_
,
_Staphylococcus _
spp.,
_Streptococcus pneunomiae_
and
_H._
_influenzae_
.
Genitourinary Tract Infections:
Pyelonephritis, cystitis, urethritis caused by susceptible strains of
_Klebsiella_
spp.,
_Enterobacter _
_aerogenes, E. coli_
,
_Enterococcus_
spp.,
_Staphylococcus_
spp.,
_Streptococcus_
spp. and gonococcal
urethritis caused by
_Neisseria gonorrhoeae. _
In adult patients with urethritis, cervicitis and vaginitis with a
positive test for
_Chlamydia trachomatis_
and/or
_Ureapla
                                
                                Przeczytaj cały dokument
                                
                            

Wyszukaj powiadomienia związane z tym produktem